Close Menu
Sarver Heart Center Grand Rounds

A Long Journey From Drug-Induced Torsades to Implementing Genomic Medicine

Presenter Details
Photo of Dan Roden, MD
Dan Roden, MD
Professor of Medicine, Pharmacology, and Biomedical Informatics and Senior Vice President for Personalized Medicine
Vanderbilt University Medical Center

Dan Roden, MD, grew up in Montreal and received his medical degree and trained in internal medicine at McGill University. He then went to Vanderbilt where, after fellowships in clinical pharmacology and cardiology, he joined the faculty and has remained since. His research program studies how genetic variation affects human disease susceptibility, with a focus on pharmacogenetics and on genetic determinants of abnormal heart rhythms, especially those induced by drugs. 

After serving as chief of the division of Clinical Pharmacology for 12 years, he was tasked in 2006 with leading Vanderbilt’s efforts in personalized medicine. Under his leadership, Vanderbilt has become internationally recognized for cutting-edge programs in this area, including the large (now >291,000 samples) biobank BioVU and the EHR-based preemptive pharmacogenetic program PREDICT.

He served as Principal Investigator for the Vanderbilt site of the Pharmacogenomics Research Network (2001-2021), and currently serves as co-PI for the Vanderbilt site of the Electronic Medical Records and Genomics (eMERGE) Network (2007-2025), and the Data and Research Center for the US All of Us program.

He has served as primary mentor for 60 post-doctoral fellows and graduate students, the majority of whom hold appointments in academic departments in the U.S., Canada, the United Kingdom, France, Germany, Italy, Denmark, Japan, Australia, and Taiwan; five currently serve as deans, department chairs, or division directors.

Dr. Roden has received the American Society for Clinical Pharmacology and Therapeutics’ Leon Goldberg Young Investigator Award, Rawls Palmer Progress in Science Award, and the Oscar Hunter Career Award; the Distinguished Scientist Award and the Douglas Zipes lectureship from the Heart Rhythm Society; the Distinguished Scientist Award and the inaugural Functional Genomics and Translational Biology Medal of Honor from the American Heart Association; the Alumnus Lifetime Achievement Award and the Louis and Artur Lucian Award in Cardiovascular Research from McGill; and the Jay and Jeanie Schottenstein prize in cardiovascular sciences from the Ohio State University.  He has been elected to membership in the American Society for Clinical Investigation and the Association of American Physicians, and fellowship in the American Association for the Advancement of Science.

Learning Objectives
  • Describe recent progress in the research, diagnosis, and treatment of heart disease
  • Integrate advances in heart disease diagnosis and treatment into the day-to-day practices of research and clinical care
  • Provide medical professionals with updates on cardiologic topics with the goals of increasing knowledge, competence ad patient care
CME Credit/Disclaimer

The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dr. Roden has disclosed he has no conflicts of interest.

All other faculty, CME Planning Committee members, and CME office reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.

12:00 pm to 1:00 pm
Friday, December 2, 2022 - 12:00pm


Tucson area
Sarver Heart Center
Room 4137
1501 N. Campbell Avenue


Charlotte Todd
College of Medicine – Tucson
Sarver Heart Center
To request any disability-related accommodations for this event please contact the event coordinator at least three business days prior to the event.